SCHEMBL26572014

SCHEMBL26572014

COC(=O)CNC(=O)c1ccc2[nH]c3ccccc3c2c1

nearest known ligand 0.80

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.80
ALDH1A1 P00352 7/20 0.80
GAA P10253 1/20 0.80
HPGD P15428 4/20 0.66
HSD17B10 Q99714 2/20 0.63
RORC P51449 1/20 0.58
MAPT P10636 4/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
MEN1 O00255 1/20 0.56
HCRTR1 O43613 1/20 0.56
RAB9A P51151 1/20 0.56
KMT2A Q03164 1/20 0.56
KIF11 P52732 1/20 0.53
LMNA P02545 1/20 0.52
HTT P42858 1/20 0.52
IMPDH2 P12268 1/20 0.49
POLB P06746 1/20 0.48
MCL1 Q07820 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30571503 1.00 KDM4E (0.80) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL26120061 0.85 KDM4E (0.71) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL4727576 0.81 KDM4E (0.78) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL13381591 0.80 KDM4E (0.83) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL13697479 0.79 KDM4E (0.69) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL71508 0.79 KIF11 (0.82) KDM4EALDH1A1GAAHPGDHSD17B10
Carbazole SCHEMBL11584093 0.76 KIF11 (0.58) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL26570393 0.76 BCAT1 (0.51) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL30209160 0.76 KIF11 (0.60) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL22100411 0.76 KIF11 (0.60) KDM4EALDH1A1GAAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed